Mengucci JF - Search Results

1

Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant.

Blum K, Chen TJ, Meshkin B, Downs BW, Gordon CA, Blum S, Mengucci JF, Braverman ER, Arcuri V, Varshavskiy M, Deutsch R, Martinez-Pons M. Blum K, et al. Among authors: mengucci jf. Adv Ther. 2006 Nov-Dec;23(6):1040-51. doi: 10.1007/BF02850224. Adv Ther. 2006. PMID: 17276971 Clinical Trial.

2

H-Wave, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: a preliminary statistical outcome study.

Blum K, DiNubile NA, Tekten T, Chen TJ, Waite RL, Schoolfield J, Martinez-Pons M, Callahan MF, Smith TL, Mengucci J, Blum SH, Meshkin B. Blum K, et al. Adv Ther. 2006 May-Jun;23(3):446-55. doi: 10.1007/BF02850166. Adv Ther. 2006. PMID: 16912027

3

The H-Wave small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study.

Blum K, Chen TJ, Martinez-Pons M, Dinubile NA, Waite RL, Schoolfield J, Blum SH, Mengucci J, Downs BW, Meshkin B. Blum K, et al. Adv Ther. 2006 Sep-Oct;23(5):739-49. doi: 10.1007/BF02850314. Adv Ther. 2006. PMID: 17142209

4

Gene \Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome.

Chen TJ, Blum K, Waite RL, Meshkin B, Schoolfield J, Downs BW, Braverman EE, Arcuri V, Varshavskiy M, Blum SH, Mengucci J, Reuben C, Palomo T. Chen TJ, et al. Adv Ther. 2007 Mar-Apr;24(2):402-14. doi: 10.1007/BF02849910. Adv Ther. 2007. PMID: 17565932 Clinical Trial.

5

Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.

Blum K, Chen TJ, Meshkin B, Waite RL, Downs BW, Blum SH, Mengucci JF, Arcuri V, Braverman ER, Palomo T. Blum K, et al. Among authors: mengucci jf. Med Hypotheses. 2007;69(5):1054-60. doi: 10.1016/j.mehy.2006.12.062. Epub 2007 Apr 30. Med Hypotheses. 2007. PMID: 17467918

6

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting.

Braverman ER, Chen TJ, Schoolfield J, Martinez-Pons M, Arcuri V, Varshavskiy M, Gordon CA, Mengucci J, Blum SH, Meshkin B, Downs BW, Blum K. Braverman ER, et al. Adv Ther. 2006 Jul-Aug;23(4):582-600. doi: 10.1007/BF02850047. Adv Ther. 2006. PMID: 17050501

7

Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Braverman ER, Chen TJ, Prihoda TJ, Sonntag W, Meshkin B, Downs BW, Mengucci JF, Blum SH, Notaro A, Arcuri V, Varshavskiy M, Blum K. Braverman ER, et al. Among authors: mengucci jf. Age (Dordr). 2007 Sep;29(2-3):55-67. doi: 10.1007/s11357-007-9030-3. Epub 2007 May 12. Age (Dordr). 2007. PMID: 19424831 Free PMC article.

8

Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.

Comings DE, Chen TJ, Blum K, Mengucci JF, Blum SH, Meshkin B. Comings DE, et al. Among authors: mengucci jf. Theor Biol Med Model. 2005 Dec 23;2:50. doi: 10.1186/1742-4682-2-50. Theor Biol Med Model. 2005. PMID: 16375770 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters